DR. SYED Z JAFRI M.D. NPI 1689619710

NPI Details

DR. Syed Z Jafri, M.D. is a cardiovascular disease internal medicine in Rock Hill, NY with 42 years of experience. The provider is an internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms. DR. Syed Z Jafri, M.D. NPI is 1689619710. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

61 EMERALD PL
ROCK HILL, NY
ZIP 12775-049
Phone: (845) 794-6999
Fax: (845) 703-6297

The NPI 1689619710 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only (HCPCS:93010)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Technetium tc-99m sestamibi, diagnostic, per study dose (HCPCS:A9500)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Anticoagulant management of patient taking warfarin (HCPCS:93793)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• Blood test, clotting time (HCPCS:85610)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, regadenoson, 0.1 mg (HCPCS:J2785)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Electrocardiogram (ecg) 2-day continuous with review and report by health care professional (HCPCS:93224)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician (HCPCS:93016)
• Hemoglobin a1c level (HCPCS:83036)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician (HCPCS:93018)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician (HCPCS:93015)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Ultrasound of heart with probe in esophagus, with report (HCPCS:93312)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Ultrasound of heart blood flow, valves and chambers (HCPCS:93320)
• Ultrasound of heart with color-depicted blood flow, rate and valve function (HCPCS:93325)
• Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report (HCPCS:93351)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)

The enumeration date for this NPI number is 6/20/2006 and was last updated on 9/29/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.